Position in NTRA
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$244,033
-$208,190 QoQ
Shares Held
899
-54.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#639
of 844 holders
Holding Since
Sep 2024
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Apollon Wealth Management, LLC holds $38,856,052 across 14 Diagnostics & Research names. NTRA ranks #14 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
32,040 | $16,063,574 | |
| 2 | DHR |
Danaher Corp /De/
|
36,041 | $6,865,089 | |
| 3 | WAT |
Waters Corp /De/
|
11,672 | $4,377,466 | |
| 4 | ICLR |
Icon PLC
|
19,819 | $3,442,758 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
5,873 | $3,091,782 | |
| 6 | DGX |
Quest Diagnostics Inc
|
6,572 | $1,392,935 | |
| 7 | A |
Agilent Technologies, Inc.
|
7,622 | $1,012,430 | |
| 8 | LH |
Labcorp Holdings Inc.
|
1,859 | $520,520 |
All Filings in NTRA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $244,033 | 899 | Shares | Sole | 2026-07-23 | |
| 2025-12-31 | $452,223 | 1,974 | Shares | Sole | 2026-01-22 | |
| 2025-03-31 | $418,432 | 2,959 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $371,213 | 2,345 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $269,514 | 2,123 | Shares | Sole | 2024-11-05 | |
| No filing history on record for this holder in this stock. | ||||||